Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in hospitalized patients with COVID-19
IRCT20200705048013N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pentoxifylline in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: arterial oxygen saturation. Started Feb 2020; status: completed.
02
Drugs
pentoxifylline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200705048013N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200705048013N1.